Abbott Reports Third-Quarter 2023 Results and Raises Midpoint of Full-Year EPS Guidance Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Abbott (ABT) gains as 'strong' performance tops Q3 expectations
October 18, 2023 8:04 AM EDTAbbott (NYSE: ABT) shares are up more than 2% premarket Wednesday after the company reported earnings, topping consensus expectations.
The medical device company reported Q3 EPS of $1.14, $0.04 better than the analyst estimate of $1.10, while revenue for the quarter came in at $10.1 billion versus the consensus... More
Abbott (ABT) Tops Q3 EPS by 4c, Raises Guidance
October 18, 2023 7:33 AM EDT(Updated - October 18, 2023 7:35 AM EDT)
Abbott (NYSE: ABT) reported Q3 EPS of $1.14, $0.04 better than the analyst estimate of $1.10 Revenue for the quarter came in at $10.1 billion versus the consensus estimate of $9.82 billion.
GUIDANCE:
Abbott sees FY2023 EPS of $4.42-$4.46, versus... More
